M 254 (Quinapril hydrochloride 20 mg)
Pill imprint M 254 has been identified as Quinapril hydrochloride 20 mg.
Quinapril is used in the treatment of left ventricular dysfunction; diabetic kidney disease; high blood pressure; heart failure; alport syndrome and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Quinapril 20 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- M 254
- Strength:
- 20 mg
- Color:
- Orange
- Size:
- 8.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Angiotensin converting enzyme inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-0254
- Inactive Ingredients:
- silicon dioxide
crospovidone
FD&C Yellow No. 6
hypromelloses
magnesium carbonate
magnesium stearate
microcrystalline cellulose
povidone
polydextrose
polyethylene glycol
sodium lauryl sulfate
triacetin
More about quinapril
Consumer resources
- Other brands: Accupril
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
